Search NLS News

ADDvise Group has entered into a share purchase agreement with the owner of Axelerist regarding the acquisition of all shares of Axelerist. Closing of the acquisition takes place today, Nov 22 2023. Axelerist Axelerist, based in Yorktown Heights, New York, is a leading provider of tailored rental and purchase solutions of MedTech- and laboratory equipment […]

The company has announced data from part 2 of its international multi-center CORIST open label phase IIa trial. The 25 enrolled patients in CORIST part 2 were heavily pretreated and no other active treatment options were available. The data documents long survival for wild type KRAS patients with metastatic colorectal cancer (mCRC) participating in the […]

An independent Data Monitoring Committee (DMC) has completed the planned dose selection analysis including safety review and assessment for futility in Induction Study 1 of the phase III program CONCLUDE. The DMC advises that cobitolimod is unlikely to meet the primary endpoint upon completion of Induction Study 1. The advice to stop the study was […]

Texray has announced the successful completion of an investment round led by Industrifonden and supported by private investors at Impilo. This round significantly exceeded expectations, highlighting the robust investor interest in Texray’s innovative technology, states the company. “We are thrilled by the immense support we have received from investors who would like to join us […]

The Life Science Bridge is a joint initiative between the regional Swedish American Chambers of Commerce in San Diego, Boston, San Francisco and Minnesota, supporting Scandinavian life science companies looking to expand to the US market. NLS asked Felicia Steinunnsdóttir, Management Associate at the Swedish American Chamber of Commerce (SACC) in San Diego, USA, about […]

Vironova BioAnalytics has announced its acquisition led by QuatreLab (a quality control company created by Columbus Venture Partners) with the participation of Accord Investment Partners and Venture Targeter AB. Following the completion of the acquisition, the company will be renamed and rebranded as QuTEM. “We are excited to join forces with these new partners to […]

Over the past ten years, the life science industry across the Nordics has shown tremendous growth. Despite some hiccups along the way caused by global upheavals, the region’s industry continues to trend upwards. Today, the five Nordic countries together boast around 700-800 life science companies, with biotech and then medtech being the most prominent areas, […]

Lecanemab was awarded the Best New Drug and the award for the Clinical Advance of the Year at the Scrip Awards 2023. The Scrip Awards celebrate the best innovations and achievements of the international biopharma industry. The award for Best New Drug recognizes excellence in pharmaceutical development and celebrates lecanemab as the first and only […]

Evinova will operate as a separate health-tech business within AstraZeneca to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes “Evinova’s globally-scaled digital health solutions are evidence-led, science-based and human experience-driven to serve clinical trial sponsors, clinical research organisations (CROs), clinical trial site care teams and patients,” states […]

The Nordic AMPlify program, available to promising Nordic digital health and medtech companies, aims to shorten time to market, kickstart a successful US growth journey and initiate co-development, partnerships, and other business opportunities. NLS asked Claudia Hidou, Head of Life Science & Healthcare, Business Sweden USA, and Rasmus Malmborg, Senior Innovation Adviser, Nordic Innovation, about […]